• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工程大肠杆菌生产 l-高丝氨酸。

Engineering Escherichia coli for l-homoserine production.

机构信息

State Key Lab of Bioreactor Engineering, Newworld Institute of Biotechnology, East China University of Science and Technology, Shanghai, China.

出版信息

J Basic Microbiol. 2023 Feb;63(2):168-178. doi: 10.1002/jobm.202200488. Epub 2022 Oct 25.

DOI:10.1002/jobm.202200488
PMID:36284486
Abstract

l-homoserine, a nonprotein amino acid, is used to synthesize many active substances in the industry. Here, to develop a robust l-homoserine-producing strain, Escherichia coli W3110 was used as a chassis to be engineered. Based on a previous construct with blocked competing routes for l-homoserine synthesis, five genes were overexpressed by promoter replacement strategy to increase the l-homoserine production, including enhancement of precursors for l-homoserine synthesis (ppc, thrA, and asd), reinforcement of the NADPH supply (pntAB) and efflux transporters (rhtA) to improve the l-homoserine production. However, the plasmid losing was to blame for the wildly fluctuating fermentation performance of engineered strains, ranging between 2.1 and 6.2 g/L. Then, a hok/sok toxin/antitoxin system was introduced into the free plasmid expression cassette to maintain the genetic stability of the episomal plasmid; consequently, the plasmid-losing rate sharply decreased, resulting in the engineered strain SHL17, which exhibited excellent stability in l-homoserine production, with 6.3 g/L in shake flasks and 44.4 g/L in a 5-L fermenter without antibiotic addition. This work verified the effective use of the hok/sok toxin/antitoxin system combined with promoter engineering to improve the genetic stability of E. coli episomal plasmids without antibiotics.

摘要

l-高丝氨酸是一种非蛋白质氨基酸,用于合成工业中的许多活性物质。在这里,为了开发出一种强大的 l-高丝氨酸生产菌株,我们使用大肠杆菌 W3110 作为底盘进行工程改造。基于之前构建的阻断 l-高丝氨酸合成竞争途径的构建体,我们通过启动子替换策略过表达了五个基因,以提高 l-高丝氨酸的产量,包括增强 l-高丝氨酸合成的前体(ppc、thrA 和 asd)、加强 NADPH 供应(pntAB)和外排转运蛋白(rhtA),以提高 l-高丝氨酸的产量。然而,质粒丢失是造成工程菌株发酵性能剧烈波动的原因,产量在 2.1 到 6.2 g/L 之间。然后,将hok/sok 毒素/抗毒素系统引入游离质粒表达盒中,以维持附加体质粒的遗传稳定性;因此,质粒丢失率急剧下降,导致工程菌株 SHL17 在生产 l-高丝氨酸方面表现出优异的稳定性,在摇瓶中达到 6.3 g/L,在 5-L 发酵罐中无需添加抗生素即可达到 44.4 g/L。这项工作验证了 hok/sok 毒素/抗毒素系统与启动子工程相结合,在不使用抗生素的情况下,有效地提高了大肠杆菌附加体质粒的遗传稳定性。

相似文献

1
Engineering Escherichia coli for l-homoserine production.工程大肠杆菌生产 l-高丝氨酸。
J Basic Microbiol. 2023 Feb;63(2):168-178. doi: 10.1002/jobm.202200488. Epub 2022 Oct 25.
2
Location and Orientation of the Genetic Toxin-Antitoxin Element hok/sok in the Plasmid Affect Expression of Pharmaceutically Significant Proteins in Bacterial Cells.遗传毒素-抗毒素元件hok/sok 在质粒中的位置和取向影响细菌细胞中药物相关蛋白的表达。
Biochemistry (Mosc). 2023 Sep;88(9):1326-1337. doi: 10.1134/S0006297923090122.
3
Balancing the AspC and AspA Pathways of by Systematic Metabolic Engineering Strategy for High-Efficient l-Homoserine Production.通过系统代谢工程策略平衡 AspC 和 AspA 途径,高效生产 l-高丝氨酸。
ACS Synth Biol. 2024 Aug 16;13(8):2457-2469. doi: 10.1021/acssynbio.4c00208. Epub 2024 Jul 23.
4
Development of a nonauxotrophic L-homoserine hyperproducer in Escherichia coli by systems metabolic engineering.通过系统代谢工程在大肠杆菌中开发非营养缺陷型 L-高丝氨酸高生产菌。
Metab Eng. 2022 Sep;73:270-279. doi: 10.1016/j.ymben.2022.08.003. Epub 2022 Aug 10.
5
Increasing L-homoserine production in Escherichia coli by engineering the central metabolic pathways.通过工程化中央代谢途径提高大肠杆菌中 L-高丝氨酸的产量。
J Biotechnol. 2020 May 20;314-315:1-7. doi: 10.1016/j.jbiotec.2020.03.010. Epub 2020 Apr 3.
6
Identification and engineering efflux transporters for improved L-homoserine production in Escherichia coli.鉴定和改造外排转运蛋白以提高大肠杆菌中L-高丝氨酸的产量。
J Appl Microbiol. 2023 Apr 3;134(4). doi: 10.1093/jambio/lxad075.
7
High-level production of l-homoserine using a non-induced, non-auxotrophic Escherichia coli chassis through metabolic engineering.通过代谢工程,使用非诱导、非营养缺陷型大肠杆菌底盘高效生产 l-高丝氨酸。
Bioresour Technol. 2021 May;327:124814. doi: 10.1016/j.biortech.2021.124814. Epub 2021 Feb 5.
8
Multiplex Design of the Metabolic Network for Production of l-Homoserine in Escherichia coli.大肠杆菌中 l-高丝氨酸生产代谢网络的多元设计。
Appl Environ Microbiol. 2020 Oct 1;86(20). doi: 10.1128/AEM.01477-20.
9
Application of plasmid stabilization systems for heterologous protein expression in Escherichia coli.质粒稳定系统在大肠杆菌中异源蛋白表达的应用。
Mol Biol Rep. 2024 Aug 28;51(1):939. doi: 10.1007/s11033-024-09881-z.
10
[Advances in the biosynthesis of L-homoserine and its derivatives by metabolic engineering of ].通过代谢工程对L-高丝氨酸及其衍生物进行生物合成的研究进展 。(原文中括号部分内容不完整,根据现有内容翻译)
Sheng Wu Gong Cheng Xue Bao. 2022 Dec 25;38(12):4385-4402. doi: 10.13345/j.cjb.220377.

引用本文的文献

1
Metabolic Engineering of for the Production of l-Homoserine.用于生产L-高丝氨酸的代谢工程
Chem Bio Eng. 2024 Jan 25;1(3):223-230. doi: 10.1021/cbe.3c00077. eCollection 2024 Apr 25.
2
Metabolic engineering strategies for L-Homoserine production in Escherichia coli.大肠杆菌中L-高丝氨酸生产的代谢工程策略。
Microb Cell Fact. 2024 Dec 19;23(1):338. doi: 10.1186/s12934-024-02623-7.
3
Enhancing tumor-specific recognition of programmable synthetic bacterial consortium for precision therapy of colorectal cancer.增强可编程合成细菌联合体对结直肠癌精准治疗的肿瘤特异性识别。
NPJ Biofilms Microbiomes. 2024 Jan 20;10(1):6. doi: 10.1038/s41522-024-00479-8.
4
Advances in Biosynthesis of Non-Canonical Amino Acids (ncAAs) and the Methods of ncAAs Incorporation into Proteins.非天然氨基酸(ncAAs)的生物合成进展及将 ncAAs 掺入蛋白质的方法。
Molecules. 2023 Sep 21;28(18):6745. doi: 10.3390/molecules28186745.